● Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

Condition: Delayed Graft Function · DGF · Kidney Transplant · Sponsor: Alexion Pharmaceuticals, Inc.

PhasePhase 3

Planned participants450

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.

This description comes directly from the study's public registry record.

Talk to the study team

Alexion Pharmaceuticals, Inc. (Sponsor) · 1-855-752-2356 · clinicaltrials@alexion.com

Always discuss trial participation with your own doctor first.

Locations (130)

Research Site	Phoenix, Arizona, United States	Recruiting
Research Site	Los Angeles, California, United States	Recruiting
Research Site	San Francisco, California, United States	Withdrawn
Research Site	San Francisco, California, United States	Recruiting
Research Site	Stanford, California, United States	Recruiting
Research Site	New Haven, Connecticut, United States	Recruiting
Research Site	Jacksonville, Florida, United States	Recruiting
Research Site	Tampa, Florida, United States	Recruiting
Research Site	Atlanta, Georgia, United States	Recruiting
Research Site	Chicago, Illinois, United States	Recruiting
Research Site	Chicago, Illinois, United States	Recruiting
Research Site	Fairway, Kansas, United States	Recruiting

+ 118 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06830798